Download the 2009 annual report in PDF format - ANF
Download the 2009 annual report in PDF format - ANF
Download the 2009 annual report in PDF format - ANF
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The extraord<strong>in</strong>ary resolutions propose:<br />
• to change <strong>the</strong> Company’s name to “<strong>ANF</strong> Immobilier”, and<br />
consequent amendment of <strong>the</strong> Articles of Association (8th<br />
resolution);<br />
• to renew <strong>the</strong> authorisation given to <strong>the</strong> Executive Board to<br />
reduce <strong>the</strong> share capital by cancell<strong>in</strong>g shares bought <strong>in</strong> <strong>the</strong> share<br />
buyback programmes, <strong>in</strong> one or more transactions, up to a limit<br />
of 10% per 24-month period (9th resolution);<br />
• to renew <strong>the</strong> Executive Board’s authorisations, delegations of<br />
authority and delegation of powers, notably <strong>in</strong> relation to <strong>the</strong> issue<br />
of shares and/or securities giv<strong>in</strong>g rights to shares:<br />
• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital by capitalis<strong>in</strong>g<br />
reserves, earn<strong>in</strong>gs or share, merger or contribution premiums,<br />
tak<strong>in</strong>g <strong>the</strong> maximum nom<strong>in</strong>al amount of <strong>the</strong> <strong>in</strong>creases <strong>in</strong><br />
capital to €25 million; <strong>in</strong> particular, this authorisation will enable<br />
<strong>the</strong> Executive Board to grant bonus allocations of shares to<br />
shareholders (10th resolution),<br />
• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital by issu<strong>in</strong>g, with<br />
pre-emptive subscription rights, shares and securities giv<strong>in</strong>g<br />
immediate or future rights to shares <strong>in</strong> <strong>the</strong> Company (11th<br />
resolution).<br />
The maximum value of shares that may be issued directly or on<br />
presentation of debt <strong>in</strong>struments is €25 million,<br />
The maximum value of securities that may be issued <strong>in</strong> relation<br />
to debt <strong>in</strong>struments is €100 million;<br />
• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital through <strong>the</strong><br />
issue of shares and/or securities conferr<strong>in</strong>g immediate and/<br />
or future rights to Company shares, without pre-emptive<br />
subscription rights by shareholders, but with a public offer, or<br />
for <strong>the</strong> purpose of remunerat<strong>in</strong>g securities that may have been<br />
contributed to <strong>the</strong> Company <strong>in</strong> <strong>the</strong> framework of a public offer<br />
with an exchange component (12th resolution).<br />
The maximum value of shares that may be issued directly or on<br />
presentation of debt <strong>in</strong>struments is €25 million.<br />
The maximum value of securities that may be issued <strong>in</strong> relation<br />
to debt <strong>in</strong>struments is €100 million.<br />
The amount of consideration owed or which may be owed<br />
subsequently to <strong>the</strong> Company for each share issued or to be<br />
issued, with<strong>in</strong> <strong>the</strong> framework of this delegation, will be at least<br />
equal to <strong>the</strong> weighted average of <strong>the</strong> open<strong>in</strong>g price over <strong>the</strong><br />
three trad<strong>in</strong>g days preced<strong>in</strong>g <strong>the</strong> date on which <strong>the</strong> issue price<br />
is set, less any tax relief provided by current legislation and<br />
regulations. This average will be corrected, where necessary, if<br />
<strong>the</strong>re are different due dates. The issue price of equity securities<br />
giv<strong>in</strong>g rights to shares <strong>in</strong> <strong>the</strong> Company would be such that <strong>the</strong><br />
sum received immediately by <strong>the</strong> Company, and, if applicable,<br />
any future proceeds likely to be received by it for each share<br />
issued as a result of <strong>the</strong> issue of <strong>the</strong> o<strong>the</strong>r securities, would be<br />
no less than <strong>the</strong> said issue price (this only applies <strong>in</strong> <strong>the</strong> context<br />
of a public offer with an exchange component).<br />
INFORMATION ABOUT <strong>ANF</strong><br />
Reports and <strong>in</strong><strong>format</strong>ion for <strong>the</strong> Shareholders’ Meet<strong>in</strong>g<br />
�<br />
Contents<br />
On <strong>the</strong> basis of this <strong>in</strong><strong>format</strong>ion, <strong>the</strong> Executive Board will set<br />
<strong>the</strong> issue price of <strong>the</strong> shares issued <strong>in</strong> <strong>the</strong> best <strong>in</strong>terest of <strong>the</strong><br />
Company and its shareholders, tak<strong>in</strong>g <strong>in</strong>to account all relevant<br />
issues.<br />
If necessary, shares issued will be placed accord<strong>in</strong>g to relevant<br />
market practices on <strong>the</strong> issue date.<br />
These last two authorisations give <strong>the</strong> Executive Board some<br />
fl exibility, if required or if <strong>the</strong> opportunity arises, to carry out<br />
immediate or deferred capital <strong>in</strong>creases (through <strong>the</strong> issue of<br />
any type of security permitted <strong>in</strong> law, such as shares, bonds,<br />
convertible bonds, warrants, etc.) without hav<strong>in</strong>g to call a<br />
Shareholders’ Meet<strong>in</strong>g,<br />
• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> share capital, with<strong>in</strong> <strong>the</strong><br />
context of an offer pursuant to Article L. 411-2 II of <strong>the</strong> French<br />
Monetary and F<strong>in</strong>ancial Code (“private placement”) and up to<br />
a limit of 20% of <strong>the</strong> Company’s capital on <strong>the</strong> date of <strong>the</strong><br />
transaction, <strong>in</strong> each 12-month period, without pre-emptive<br />
subscription rights, through <strong>the</strong> issue of ord<strong>in</strong>ary shares and/<br />
or securities giv<strong>in</strong>g immediate and/or future rights to a portion<br />
of <strong>the</strong> Company’s capital (13th resolution).<br />
The maximum value of securities that may be issued <strong>in</strong> relation<br />
to debt <strong>in</strong>struments is €100 million.<br />
The amount of consideration owed or which may be owed<br />
subsequently to <strong>the</strong> Company for each share issued or to be<br />
issued, with<strong>in</strong> <strong>the</strong> framework of this delegation, will be at least<br />
equal to <strong>the</strong> weighted average of <strong>the</strong> open<strong>in</strong>g price over <strong>the</strong><br />
three trad<strong>in</strong>g days preced<strong>in</strong>g <strong>the</strong> date on which <strong>the</strong> issue price<br />
is set, less any tax relief provided by current legislation and<br />
regulations. This average will be corrected, where necessary, if<br />
<strong>the</strong>re are different due dates. The issue price of equity securities<br />
giv<strong>in</strong>g rights to shares <strong>in</strong> <strong>the</strong> Company would be such that <strong>the</strong><br />
sum received immediately by <strong>the</strong> Company and, if applicable,<br />
any future proceeds likely to be received by it for each share<br />
issued as a result of <strong>the</strong> issue of <strong>the</strong> o<strong>the</strong>r securities, would be<br />
no less than <strong>the</strong> said issue price.<br />
On <strong>the</strong> basis of this <strong>in</strong><strong>format</strong>ion, <strong>the</strong> Executive Board will set<br />
<strong>the</strong> issue price of <strong>the</strong> shares issued <strong>in</strong> <strong>the</strong> best <strong>in</strong>terest of <strong>the</strong><br />
Company and its shareholders, tak<strong>in</strong>g <strong>in</strong>to account all relevant<br />
issues.<br />
If necessary, shares issued will be placed accord<strong>in</strong>g to relevant<br />
market practices on <strong>the</strong> issue date.<br />
This authorisation gives <strong>the</strong> Executive Board <strong>the</strong> option, if<br />
appropriate, to carry out a private placement to generate,<br />
quickly and fl exibly, <strong>the</strong> funds necessary to fi nance <strong>the</strong><br />
Company’s growth,<br />
• <strong>the</strong> authorisation, <strong>in</strong> <strong>the</strong> case of a capital <strong>in</strong>crease, to set <strong>the</strong><br />
price of shares or securities giv<strong>in</strong>g immediate and/or future<br />
rights to shares, without pre-emptive subscription rights, up to<br />
a limit of 10% of <strong>the</strong> share capital (14th resolution),<br />
• <strong>the</strong> authorisation to <strong>in</strong>crease <strong>the</strong> number of shares, <strong>in</strong>struments<br />
or securities to be issued <strong>in</strong> <strong>the</strong> case of an <strong>in</strong>crease <strong>in</strong> <strong>the</strong><br />
<strong>ANF</strong> • <strong>2009</strong> ANNUAL REPORT<br />
99<br />
OTHER GENERAL GENERAL INFORMATION PRO FORMA FINANCIAL INFORMATION ANNUAL ANNUAL FINANCIAL STATEMENTS CONSOLIDATED FINANCIAL FINANCIAL STATEMENTS INFORMATION ABOUT <strong>ANF</strong> DESCRIPTION OF THE BUSINESS